These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31241019)
1. Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer. Elhossary M; Hawash N; Badawi R; Yousef M; Abd-Elsalam S; Elhendawy M; Wasfy R; Abou-Saif S; ElBendary A; Ismail S Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):302-312. PubMed ID: 31241019 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554 [TBL] [Abstract][Full Text] [Related]
3. Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial. Hurt C; Ramaraj R; Farr A; Morgan M; Williams N; Philips CJ; Williams GT; Gardner G; Porter C; Sampson J; Hillier S; Heard H; Dolwani S; Lancet Gastroenterol Hepatol; 2019 May; 4(5):364-375. PubMed ID: 30885505 [TBL] [Abstract][Full Text] [Related]
4. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Hüneburg R; Lammert F; Rabe C; Rahner N; Kahl P; Büttner R; Propping P; Sauerbruch T; Lamberti C Endoscopy; 2009 Apr; 41(4):316-22. PubMed ID: 19340735 [TBL] [Abstract][Full Text] [Related]
5. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer. Knychalski B; Lukieńczuk T Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741 [TBL] [Abstract][Full Text] [Related]
6. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Kahi CJ; Anderson JC; Waxman I; Kessler WR; Imperiale TF; Li X; Rex DK Am J Gastroenterol; 2010 Jun; 105(6):1301-7. PubMed ID: 20179689 [TBL] [Abstract][Full Text] [Related]
7. Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation. Xue G; Wang X; Yang Y; Liu D; Cheng Y; Zhou J; Cao Y PLoS One; 2014; 9(4):e94252. PubMed ID: 24710115 [TBL] [Abstract][Full Text] [Related]
8. Further validation of magnifying chromocolonoscopy for differentiating colorectal neoplastic polyps in a health screening center. Emura F; Saito Y; Taniguchi M; Fujii T; Tagawa K; Yamakado M J Gastroenterol Hepatol; 2007 Nov; 22(11):1722-7. PubMed ID: 17565585 [TBL] [Abstract][Full Text] [Related]
10. Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study. Lee JH; Hong SP; Jeon TJ; Kang GH; Choi WC; Jeon SM; Moon CM; Park JJ; Cheon JH; Kim TI; Kim WH Dig Dis Sci; 2011 Aug; 56(8):2396-403. PubMed ID: 21327920 [TBL] [Abstract][Full Text] [Related]
11. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer. Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558 [TBL] [Abstract][Full Text] [Related]
12. Could the colonic capsule PillCam Colon be clinically useful for selecting patients who deserve a complete colonoscopy?: results of clinical comparison with colonoscopy in the perspective of colorectal cancer screening. Gay G; Delvaux M; Frederic M; Fassler I Am J Gastroenterol; 2010 May; 105(5):1076-86. PubMed ID: 19888198 [TBL] [Abstract][Full Text] [Related]
13. Contribution of the OC Sensor Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183 [TBL] [Abstract][Full Text] [Related]
14. [Colonoscopy in the screening, follow-up and treatment of colorectal cancer and precursor lesions]. Pellisé M Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():71-7. PubMed ID: 26520199 [TBL] [Abstract][Full Text] [Related]
15. Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer. Qiu S; Nikolaou S; Fiorentino F; Rasheed S; Darzi A; Cunningham D; Tekkis P; Kontovounisios C Horm Cancer; 2019 Jun; 10(2-3):128-135. PubMed ID: 31093954 [TBL] [Abstract][Full Text] [Related]
16. Advances in endoscopic imaging of colorectal neoplasia. Wallace MB; Kiesslich R Gastroenterology; 2010 Jun; 138(6):2140-50. PubMed ID: 20420951 [TBL] [Abstract][Full Text] [Related]
17. Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy. Hurlstone DP; Cross SS; Slater R; Sanders DS; Brown S Gut; 2004 Mar; 53(3):376-80. PubMed ID: 14960519 [TBL] [Abstract][Full Text] [Related]
18. Comparison of probe-based confocal laser endomicroscopy with virtual chromoendoscopy for classification of colon polyps. Buchner AM; Shahid MW; Heckman MG; Krishna M; Ghabril M; Hasan M; Crook JE; Gomez V; Raimondo M; Woodward T; Wolfsen HC; Wallace MB Gastroenterology; 2010 Mar; 138(3):834-42. PubMed ID: 19909747 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer. Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated DNA mutation detection in individuals undergoing colonoscopy. Fleshner P; Braunstein GD; Ovsepyan G; Tonozzi TR; Kammesheidt A Cancer Med; 2018 Jan; 7(1):167-174. PubMed ID: 29125240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]